Responding to unmet needs for metastatic castration-resistant prostate cancer
Thank you for completing the questionnaire
Thank you for completing our short feedback survey. Your answers will help us further refine and expand our selection of educational materials on Medthority, and tailor content to your needs as a healthcare professional interested in management of metastatic castration-resistant prostate cancer.
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, who has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.